Quote from Stockwits re; TNBC paper
$CYDY
new paper out on CCR-5 and breast cancer with Leronlimab mentions.
mdpi.com/1422-0067/23/22/14...
Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-